Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, May 2026 and Aug 2026.
- Largest single sale: $789K (18,838 shares) of Exelixis, Inc. on Nov 11, 2025. Filing
- Last sale before this period: Feb 14, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Exelixis, Inc. (EXEL) | Director | Jan 9, 2024 | Aug 12, 2026 |
| Johnson & Johnson (JNJ) | Director | Feb 10, 2016 | Apr 27, 2026 |
Also a director at
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 10, 2026, Exelixis, Inc.: sold 9,812 shares for $527K, under a disclosed plan. 1 filing: 1
- May 27, 2026, Exelixis, Inc.: 8,367 shares granted. 1 filing: 1
- May 7, 2026, Exelixis, Inc.: sold 7,712 shares for $374K, no plan disclosed; 3,856 shares acquired by exercising options. 1 filing: 1
- Nov 11, 2025, Exelixis, Inc.: sold 24,622 shares for $1.0M, no plan disclosed; 5,784 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.